Citation Impact
Citing Papers
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study
2006
The risk associated with indwelling catheters in children with haemophilia
2007
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
2003 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Green Chemistry: Principles and Practice
2009 Standout
Workplace safety: A meta-analysis of the roles of person and situation factors.
2009 Standout
Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers
2005
Chitosan-based hydrogels for controlled, localized drug delivery
2009 Standout
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products
2005
International workshop on immune tolerance induction: consensus recommendations1
2007
Orthopaedic surgery of haemophilia in the 21st century: an overview
2002
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Antibacterial anti-oxidant electroactive injectable hydrogel as self-healing wound dressing with hemostasis and adhesiveness for cutaneous wound healing
2017 Standout
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience
2007
Consensus recommendations for use of central venous access devices in haemophilia
2004
The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization
2006
Home management of haemophilia
2004
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Accident proneness, does it exist? A review and meta-analysis
2006
Central venous access devices in haemophilia
2004
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations
2011
Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentrates
2003
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications
2003 Standout
Disseminated Intravascular Coagulation
1999 Standout
Liposomes as nanomedical devices
2015 Standout
Haemophilias A and B
2003
Protein therapeutics: a summary and pharmacological classification
2007 Standout
European principles of haemophilia care
2008
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Management of arthrofibrosis in haemophilic arthropathy
2010
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high‐titre inhibitors
2007
Application of chitosan, a natural aminopolysaccharide, for dye removal from aqueous solutions by adsorption processes using batch studies: A review of recent literature
2007 Standout
The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
2002
The Effect of DDAVP Infusion on Thrombin Generation in Platelet-rich Plasma of von Willebrand Type 1 and in Mild Haemophilia A Patients
2000
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Pharmacokinetics of Coagulation Factors
2001
Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy
2019
Chitin and chitosan polymers: Chemistry, solubility and fiber formation
2009 Standout
Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing Surgery
1998
Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids
2009 Standout
ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor
2009
Main properties and current applications of some polysaccharides as biomaterials
2007 Standout
Polyacrylamide-Chitosan Hydrogels: In Vitro Biocompatibility and Sustained Antibiotic Release Studies
2000
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
2001
Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications
2015 Standout
Heparin Blunts Endotoxin-Induced Coagulation Activation
1999
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Chitin and chitosan: Properties and applications
2006 Standout
Guidelines for the management of hemophilia
2012 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
2008
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Works of M. Heim being referenced
Feasibility of using recombinant factor VIIa in continuous infusion.
1996
The use of the Port‐A‐Cath in children with haemophilia — a review
1998
When should prophylactic treatment in patients with haemophilia A and B start?— The German experience
1998
Prions and haemophilia: assessment of risk
1998
Management of haemophilia B patients with inhibitors and anaphylaxis
1998
Synovium in haemophilic arthropathy
1998
Novel delivery systems for coagulation proteins
1998
The management of factor XI deficiency
1998
Haemophilia treatment protocols around the world: towards a consensus
1998
The fixed flexed and subluxed knee in the haemophilic child: what should be done?
1996
Guidelines on treatment of haemophilia in Sweden
1998
Treatment protocol of haemophilia and other congenital bleeding disorders in Italy
1998
Accidents among high school pupils in Israel: a recurrent disease?
1997
Feasibility of Using Recombinant Factor VIIa in Continuous Infusion
1996